Alcoholic liver disease: A current molecular and clinical perspective
Heavy alcohol use is the cause of alcoholic liver disease (ALD). The ALD spectrum ranges from alcoholic steatosis to steatohepatitis, fibrosis, and cirrhosis. In Western countries, approximately 50% of cirrhosis-related deaths are due to alcohol use. While alcoholic cirrhosis is no longer considered...
Main Authors: | Koichiro Ohashi, Michael Pimienta, Ekihiro Seki |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2018-12-01
|
Series: | Liver Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2542568418300333 |
Similar Items
-
Acrolein, a New Villain in the Development of Alcoholic Liver Disease
by: Ekihiro Seki MD,, PhD
Published: (2016-09-01) -
Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis
by: Yoon Mee Yang, et al.
Published: (2018-07-01) -
FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
by: Jieun Kim, et al.
Published: (2023-01-01) -
Nuclear Receptors: Opening Up New Avenues of Pediatric Fatty Liver Research
by: Vijay Pandyarajan, et al.
Published: (2018-10-01) -
In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and LimitationsSummary
by: Young-Sun Lee, et al.
Published: (2023-01-01)